Ossiform

Ossiform

Del

Ossiform® is a British-Danish MedTech company that develops bio-integrative bone substitutes, tailored to improve bone healing outcomes, simplify complex procedures, and reduce complication rates in orthopedics and spine.

02/06/2026

How can bone-mimicking scaffolds be used in cancer research? 🦴

While cancer research has come far with the use of traditional 2D cell cultures and various animal models, three-dimensional tumor models – also called tumoroids – are an emerging tool within the field.

Tumoroids have the ability to replicate key features of the tumor micro-environment, which in turn offer a more physiologically relevant disease model that retains the biological characteristics of the primary tumor🧫

Tumoroids are typically derived from patient cancer cells or immortalized cancer cell lines and they can enable:
- Studies of tumor-matrix interactions
- Evaluation of anticancer therapies
- Investigation of metastatic mechanisms

Many solid tumors and cancer types – including breast and prostate cancer – metastasize to our bones. Yet bone metastasis remains one of the most difficult aspects of cancer biology to model in vitro due to the complexity of the tissue.
By providing a mineralized, bone-mimicking microenvironment, the P3D Scaffolds from Ossiform enable researchers to grow 3D tumoroids that accurately replicate the tumor-host tissue interactions in a physiologically relevant setting without the use of animal models🐀

Such bone cancer model makes it possible to:
- Investigate how cancer cells colonize and adapt to bone
- Study metastatic mechanisms in a controlled system
- Screen anticancer therapies with improved translational relevance

As the field moves toward scalable, human-relevant research platforms, tumoroids represent a powerful alternative to traditional 2D cultures and many animal models.

Learn more about how P3D Scaffolds and tumoroids advance bone metastasis research and therapeutic development: https://ossiform.com/how-miniature-tumors-can-be-grown-on-p3d-scaffolds-for-cancer-research/

07/05/2026

We’re excited to share that Ossiform is heading to Tennessee as part of the ABHI US Accelerator 2026!

From 11–15 May, we’ll be in Memphis and Nashville, meeting with senior leaders, innovation teams, and clinicians across leading health systems, including Baptist Memorial Health, Vanderbilt University Medical Center, LifePoint, HCA, and many more🩺

A fantastic opportunity to showcase Ossiform and explore new collaborations in the US market. Looking forward to a great week of conversations💬

Vil du plassere din virksomhed på toppen av Ingeniørvirksomhed-listen i Odense?
Klik her for at gøre krav på din sponsorerede post.

Telefon

Adresse


Oslogade 1
Odense
5000